Why the Certificate of Analysis Is Your First Stop
When a research peptide arrives at the laboratory, the Certificate of Analysis (COA) should be the first document a scientist examines—before the vial is even opened. A COA is the supplier's formal record that a specific batch of peptide has been tested and meets defined quality parameters. Understanding every line of that document is not a bureaucratic exercise; it directly affects the reproducibility, interpretability, and scientific validity of downstream experiments.
This guide walks through the standard fields found on a research-peptide COA, explains the analytical methods behind them, and highlights the questions a researcher should ask when something looks unusual.
Batch and Lot Identification
At the top of any COA you will find identifiers that tie the document to a single, unique production run. These typically include:
- Catalog number: The supplier's product identifier. Confirm this matches what you ordered exactly, including any suffix that may indicate salt form or modification.
- Lot or batch number: A alphanumeric code unique to one synthesis run. This number is critical for traceability; if experimental results differ between orders, comparing lot numbers is the starting point for investigation.
- Manufacturing and expiry dates: Peptides degrade over time through hydrolysis, oxidation, and aggregation. An expiry date is a supplier's estimate of when the material may no longer meet its stated specifications under recommended storage conditions.
- Net quantity: Reported in milligrams or micrograms. Note whether this is gross weight or peptide content corrected for moisture and counterions (see below).
Retaining the COA alongside your laboratory notebook entry for every experiment is standard good practice and is required by many institutional compliance frameworks.
Purity: The Most Scrutinized Field
Purity is almost always expressed as a percentage and is the figure most researchers focus on first. However, understanding what that percentage actually means requires knowing the method used to generate it.
HPLC Purity
The vast majority of research-peptide suppliers determine purity by reversed-phase high-performance liquid chromatography (RP-HPLC). The peptide sample is injected onto a C18 or C8 column, separated by a gradient of aqueous and organic solvents, and detected by ultraviolet absorbance—most commonly at 220 nm, which captures the peptide bond, or at 254 nm if the sequence contains aromatic residues.
Purity is then calculated as the area percentage of the main peak relative to the total integrated peak area. A value of ≥95% is commonly considered suitable for most biochemical and cell-based research applications, while some highly sensitive assays may require ≥98%. It is important to recognise that HPLC area-percent purity is a relative measurement; it describes the chromatographic profile, not an absolute molar quantity of correct peptide.
When reviewing HPLC data, look for whether the supplier provides the actual chromatogram or only the numerical result. Access to the raw chromatogram allows you to assess peak shape, the presence of shoulders that may indicate closely eluting impurities, and baseline resolution.
What HPLC Purity Does Not Capture
HPLC cannot easily distinguish a correctly folded, biologically relevant peptide from a truncated or scrambled sequence that happens to co-elute. This is why identity confirmation by mass spectrometry is an essential complement to HPLC purity, not an optional extra.
Identity Confirmation by Mass Spectrometry
A COA for a research peptide should include mass spectrometry (MS) data confirming that the observed molecular mass matches the theoretical molecular mass of the target sequence. The most common technique reported is electrospray ionisation mass spectrometry (ESI-MS), which generates multiply charged ions and is well-suited to peptides in the 500–5000 Da range.
On the COA, look for:
- Theoretical molecular weight (MW): Calculated from the amino acid sequence and any modifications (e.g., amidated C-terminus, acetylated N-terminus, disulfide bonds).
- Observed MW: The experimentally determined value. Agreement within ±1 Da (or within the instrument's stated mass accuracy, often ±0.1% for ESI) is expected.
- Charge states observed: ESI-MS typically shows [M+H]⁺, [M+2H]²⁺, and higher charge states. Multiple consistent charge states strengthen confidence in the assignment.
A mismatch between theoretical and observed MW is a serious flag. Common causes include incomplete deprotection of side chains during synthesis, missed couplings resulting in truncated sequences, or unanticipated modifications such as oxidation of methionine (+16 Da) or deamidation of asparagine (+1 Da).
Moisture Content and Peptide Content
Lyophilised peptides absorb atmospheric moisture and may also carry residual counterions (most commonly trifluoroacetate from HPLC purification or acetate from salt exchange). This means the gross mass in the vial is not equal to the mass of peptide available for your experiment.
Some suppliers report moisture content determined by Karl Fischer titration and/or counterion content determined by ion chromatography. Where these values are provided, the peptide content (sometimes called net peptide content) can be calculated:
Peptide content (%) = 100% − moisture (%) − counterion content (%) − other impurities (%)
If a supplier reports only HPLC purity without addressing moisture and counterion load, researchers working with gravimetric dosing in quantitative assays should account for this potential discrepancy when preparing stock solutions. Where absolute concentration is critical, preparing solutions by weight and then verifying concentration spectrophotometrically (for sequences containing Trp, Tyr, or Phe) or by amino acid analysis is advisable.
Additional Analytical Fields You May Encounter
- Appearance: A visual or descriptive assessment (e.g., white to off-white powder). Significant deviation—such as unexpected coloration—may indicate degradation or impurity carry-over and warrants further investigation.
- Solubility: Suppliers sometimes test solubility in water, DMSO, or dilute acid/base. This is a useful starting point but does not replace in-house solubility optimisation for specific buffer systems.
- Endotoxin testing: For peptides intended for use in cell-based assays where lipopolysaccharide contamination would confound results, a limulus amebocyte lysate (LAL) test result may be included. Note the units (EU/mg) and the threshold relevant to your assay type.
- Amino acid analysis (AAA): A rigorous technique that hydrolyses the peptide and quantifies individual amino acids. When present, it provides confirmation of sequence composition and can give an accurate net peptide content figure.
Red Flags and Questions to Ask Your Supplier
Not all COAs are created equal. Researchers should be cautious when a document omits MS data entirely, reports purity without specifying the analytical method, or presents a lot number that cannot be cross-referenced with the supplier's quality system. Legitimate suppliers should be willing to provide full chromatograms, MS spectra, and method details upon request. If a COA lists only a single-digit purity percentage with no supporting data, that is an insufficient basis for scientific conclusions.
Filing and Version Control
Store a digital or physical copy of each COA with the corresponding experimental records. If a supplier issues a corrected COA—which can happen following instrument recalibration or data review—note the version date and update your files accordingly. This discipline supports the audit trail required for reproducible research and, where applicable, regulatory submissions.
For research use only. The information in this article is intended solely to support laboratory scientists in evaluating analytical documentation for research-grade peptides. Nothing herein constitutes medical advice, guidance on human or veterinary use, or recommendations regarding dosing or therapeutic application.